Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and application of induced neural stem cells

A technology of neural stem cells and neural precursor cells, which is applied in the fields of neural stem cells and biomedicine, can solve the problems of easily polluted cell sources, no report on the transplantation of dopaminergic neural precursor cells, and gene mutation of host cells.

Active Publication Date: 2019-11-01
WISEHEART MEDICAL VALLEY CO LTD
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

1. The acquisition of fibroblasts is relatively traumatic, and it is difficult to culture fibroblasts in vitro
2. The source of cells is easily polluted. For example, cells obtained from urine are easily polluted during the operation, especially urine obtained from wards is more likely to be polluted
3. Integrative viral vectors may cause gene mutations in host cells
[0005] The cell therapy of Parkinson's disease has attracted the attention of many medical workers and scholars in the field of biology in the past 20 years, but there is no report on the transplantation of dopaminergic neural precursor cells derived from the differentiation of induced neural stem cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and application of induced neural stem cells
  • Method and application of induced neural stem cells
  • Method and application of induced neural stem cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Example 1 Inducing Peripheral Blood Mononuclear Cells to Differentiate into Neural Stem Cells

[0079] Step 1: Separation of mononuclear cells in blood.

[0080] (1) At room temperature, 6ml of adult peripheral venous blood was collected, stored in a heparin anticoagulant tube, and mixed up and down 5 times.

[0081] (2) Mononuclear cells were collected by density gradient centrifugation: the peripheral blood was diluted 1:2 with PBS, and stored in a 50ml centrifuge tube at room temperature. If the diluted blood was not enough for 35ml, it was replenished with PBS.

[0082] (3) Take another 50ml centrifuge tube to hold 15ml of Ficoll-Paque Premium, and then tilt it at 45 degrees so that the diluted blood slowly flows into the tube of Ficoll-Paque Premium.

[0083] (4) Centrifuge at 25 degrees for 30 minutes at a speed of 750g, and turn off the centrifuge brake during centrifugation.

[0084] (5) After centrifugation, the upper layer of the centrifuge tube is the plasm...

experiment example 2

[0104] Experimental Example 2 Inducing Neural Stem Cells to Express Neural Stem Cell Marker Proteins

[0105] The induced neural stem cells were divided into 5×10 4 Inoculated on polylysine and laminin-coated 12mm glass slides, cultured in neural stem cell culture medium for 48 hours and then stained, the specific steps are:

[0106] (1) Aspirate the medium, wash twice with PBS, and then add 4% paraformaldehyde to fix for 10 minutes.

[0107] (2) Absorb paraformaldehyde, add 0.3% PBST 1ml, repeat 3 times, each interval is 5 minutes.

[0108] (3) Add 3% donkey serum to block for 1 hour at room temperature. 4. After 1 hour, add the primary antibody, respectively add antibodies such as Nestin (1:500Mouse BD bioscience), Sox1 (1:200Goat BD bioscience) to 1% donkey serum in proportion, and then incubate the cells at 4 degrees overnight.

[0109] (4) Remove the primary antibody and add the corresponding secondary antibody. Donkey anti-mouse FITC corresponds to Nestin at a ratio ...

experiment example 3

[0112] Experimental Example 3 Neural stem cells were differentiated into mature neurons.

[0113] Neural stem cells were divided into 2×10 4 Inoculated on polylysine and laminin-coated 12mm glass slides, cultured in neural stem cell medium for 24 hours, then replaced the medium with neuron differentiation medium, the composition of which was DMEM:F12, 1% N2, 1 %B27, 1% Glutamine, 1% non-essential amino acid NEAA (Life Technologies), the medium was changed every other day, and the cells were fixed after 6 weeks for immunocytochemical staining. Specifically MAP2 (1:200Mouse Sigma), Neun (1:400RabbitMillpore), expressing mature neuronal protein Map2Neun, such as Figure 9 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method of induced neural stem cells and a composition. Through the method and the composition, peripheral blood mononuclear cells can be induced to form neural stem cells. The neural stem cells can express neural stem cell related genes, and can disintegrate out nerve cells, astroglia cells and oligodendrocyte. Dopaminergic nerve precursor cells formed through in vitro induction and disintegration of the neural stem cells are transplanted into the striatum corpora of a PD mouse model, no tumors are formed, the ethology of a mouse Parkinson 's disease model can be improved, and the process of the Parkinson 's disease can be delayed. The neural stem cell inducing and disintegrating method provided by the invention is simple and quick to operate, small in traumatic occlusion and good in safety, and is hopefully used for treating the Parkinson 's disease.

Description

technical field [0001] The present invention relates to the field of biomedicine and the technical field of neural stem cells, in particular to a method for inducing neural stem cells using a non-integrated, temperature-inactivating Sendai virus vector and the use of dopaminergic neural precursor cells of directed differentiation in Parkinson's disease cell transplantation therapy the use of. Background technique [0002] Stem cell transplantation brings hope for the treatment of many neurological diseases, such as Parkinson's disease, amyotrophic lateral sclerosis, brain and spinal cord trauma, etc. Studies have shown that the use of neural stem cells derived from embryonic stem cells has certain effects in the treatment of the above diseases, but the tumorigenicity of embryonic stem cells, immune rejection of allogeneic transplantation, and ethical disputes limit its application. Induced pluripotent stem cells (iPSCs) were obtained from human fibroblasts and differentiate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/079C12N5/0793C12N5/0797A61K35/30A61P25/00A61P9/10A61P25/16
CPCC12N5/0623C12N5/0619C12N5/0618A61K35/30A61P25/00A61P9/10A61P25/16C12N2506/11A61K39/461A61K2239/38A61K39/46432A61P25/28C12N15/86C12N2760/18843C12N2501/60C12N2506/115A61K35/15C12N5/0606C12N2501/01C12N5/0696C12N2501/13C12N2501/15C12N5/0018
Inventor 陈志国袁艳鹏唐玺和张愚
Owner WISEHEART MEDICAL VALLEY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com